Carlos V. Paya, President and CEO at Immune Design Corp. (IMDZ), sold 3,940 shares at $5.35 ($21K) on 2017-01-04, disclosed to the SEC on 2017-01-06.
Scheduled sale ($21k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| IMDZ | SELL | 2018-01-08 | $33K | — | Filing → |